Stocks Showing Improving Market Leadership: Beigene Earns 81 RS Rating

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Beigene (BGNE) now clears that threshold, with a jump from 74 to 81 Monday.


When you’re researching the best stocks to buy and watch, keep a close on eye on relative price strength.

IBD’s proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock’s price performance over the last 52 weeks stacks up against all the other stocks in our database.

Decades of market research reveals that the best-performing stocks often have an RS Rating of at least 80 in the early stages of their moves.

Looking For The Best Stocks To Buy And Watch? Start Here

Beigene is trying to complete a consolidation with a 389.07 entry. See if it can clear the breakout price in heavy trading. It’s a later-stage pattern, and investors should be aware that those are less likely to lead to significant gains.

The company reported -21% earnings growth in the latest quarterly report, while sales growth came in at 129%.

The company holds the No. 39 rank among its peers in the Medical-Biomed/Biotech industry group. Regeneron Pharmaceutical (REGN) and Dynavax Technologies (DVAX) are also among the group’s highest-rated stocks.


Biotech And Pharmaceutical Industry And Stock News

IBD Stock Rating Upgrades: Rising Relative Strength

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Evaluate Any Stock With Stock Ratings, IBD Charts And Stock Checkup

Most Related Links :
honestcolumnist Governmental News Finance News

Source link

Back to top button